UKCPA Autumn Symposium Progress in Practice Programme Overview Crowne Plaza, Nottingham Friday 21st - Saturday 22nd November 2014 The UKCPA promotes expert practice in medicines management for the benefit of patients, the public and members by establishing standards, workforce development and advancing innovation in all health care settings The UKCPA encourages Excellence, Leadership and Partnership Sponsored by: Endorsed by: Programme - UKCPA Autumn Symposium 2014 Friday 21st November 09.00 09.45 09.55 10.10 10.40 12.10 12.15 14.10 Registration desk opens, arrival refreshments served Convene in plenary suite for commencement of symposium Chair’s Introduction and Symposium Opening Keynote Lecture: Making Change Work: Improvement Science Demystified Dr Clare Crowley, Consultant Pharmacist – Medicines Safety, Oxford University Hospitals NHS Trust Oral Communications Lunch and official opening of the Medical Exhibition First Time Attendees Welcome Meeting Work session 1 (5 x concurrent sessions) a) Faculty Portfolio Building Surgery: Give your portfolio a health check! (suitable for all levels) Helen Middleton MSc (Education), MRPharmS, FFRPS, joint Chair of the UKCPA Education & Training Group and Professional Development Manager at London Pharmacy Education and Training, plus RPS Faculty Members and Fellows If you answer “Yes” to any of these questions, this interactive workshop is for you! Are you seeking professional recognition by the RPS Faculty? Started your portfolio and looking for support and feedback from those who have been through the process? Suffering from mapping madness? Want to know if you are on the right track? Would your portfolio benefit from a health check? This workshop will give you the opportunity to discuss your own portfolio with the Faculty Development Leads, Faculty Members and Fellows and your peers. Delegates will be expected to bring their portfolio transcript, a portfolio entry and/or ideas for evidence in relation to the Advanced Pharmacy Framework for discussion at the workshop. The workshop will be tailored to individual needs and there will be opportunities for one to one and small group support. b) Consultation skills for challenging patients – substance misuse and alcohol (I/II) David Gibson, UKCPA General Committee Member and Lead Clinical Pharmacist, Darlington Memorial Hospital, County Durham The aim of this session is to share good practice about how to approach a consultation. The focus will be on those challenging patient groups where it is often difficult to get engagement about their medication. Learning outcomes: At the end of this session participants will be able to: Review different consultation models and how pharmacists apply them in everyday practice Consider the challenges associated with patients who misuse substances or alcohol Share good practice about how we adapt our consultation style to best meet the needs of these patients c) New inhaled drugs for asthma and COPD: integration into UK Asthma and COPD guideline management (II) Toby Capstick, joint Chair of the UKCPA Respiratory Group and Lead Respiratory Pharmacist, Leeds Teaching Hospitals NHS Trust and Hasanin Khachi, joint Chair of the UKCPA Respiratory Group & Highly Specialist Pharmacist - Respiratory Medicine, Barts Health NHS Trust The aim of this session is to discuss the risks and benefits of new inhaled therapies in respiratory conditions, and support their evidence-based integration into asthma and COPD management. Learning outcomes: At the end of this session participants will be able to: Compare the evidence for new drug therapies and contrast to existing therapies 15.40 16.25 16.25 16.55 17.15 17.30 19.00 Analyse the advantages and disadvantages of new inhaler devices in order to assess suitability for prescribing for different patient cohorts Justify the cost-effective basis for guideline-based management of asthma and COPD in future management d) Working with the Pharmaceutical Industry to improve patient care (I) Richard Wysocki MRPharmS, Medical Affairs Director/EU Qualified Person for Pharmacovigilance, hameln pharmaceuticals ltd, Gloucester, UK and Dr Clare Crowley, Consultant Pharmacist – Medicines Safety, Oxford University Hospitals NHS Trust The aim of this session is to consider how positive patient outcomes can be delivered through effective interaction between the Pharmacy Profession and the Pharmaceutical Industry. Learning outcomes: At the end of this session participants will be able to: Recognise and evaluate opportunities within your own professional environment for effective engagement with the Pharmaceutical Industry Apply examples of good practice described by your colleagues to your own professional environment Manage barriers and propose solutions to enable effective interaction with the Pharmaceutical Industry within your own professional environment e) What every pharmacist needs to know about skin disease (F) Dr Christine Clark, Freelance medical writer and pharmaceutical consultant with special expertise in dermatology, Rossendale, Lancashire and Dr Gillian Hawksworth, UKCPA Trustee Member and Senior Lecturer University of Huddersfield, Yorkshire. The aim of this session is to provide a rapid overview of the management of the three inflammatory skin diseases and identify key interventions that improve effective use of medicines in patients who have eczema, psoriasis or acne. Learning outcomes: At the end of this session participants will be able to: Describe the prevalence and natural history of eczema, psoriasis and acne State the current first-line treatment recommendations for the treatment of eczema, psoriasis and acne and be aware of the guidelines from which they are drawn For each disease - eczema, psoriasis and acne - list three key points that can make treatment more effective Explain the implications of chronic skin disease for hospital inpatients and the importance of effective treatment Medical Exhibition and refreshments Medical Exhibition closes UKCPA Members Presentations, Plenary Suite: Pharmacy “eight days a week”, Victoria Hill, Lead Pharmacist – Unscheduled Care, Bradford Teaching Hospitals NHS Foundation Trust Behavioural insights and nudge theory, Ewan Maule, Deputy Chief Pharmacist – Operational Services, Northumberland Tyne and Wear NHS Foundation Trust UKCPA Clinical Research Grant 2013 Update: Errors in the Preparation of injectable Medicines in the Pharmacy Environment: A Failure Modes and Effects Analysis, K Lynette James, Department of Pharmacy and Pharmacology, University of Bath Official opening of the Poster Exhibition First Time Attendees Welcome Meeting (for those unable to attend the earlier meeting) Pre Dinner Drinks followed by Symposium Dinner at 19.30 To include the announcement of the UKCPA Lifetime Achievement Award 2014 winner. Music and dancing to follow. Saturday 22nd November 08.00 09.00 09.30 Breakfast Meetings Registration desk opens/poster exhibition viewing Work session 2 (5 x concurrent sessions) a) Embedding professionalism, attitudes and values (suitable for all levels) Aamer Safdar, UKCPA Education & Training Group and General Committee Member, and Principal Pharmacist Lead for Education and Development, Guy's and St Thomas' NHS Foundation Trust and Abbas Alidina, UKCPA Education & Training Group Committee Member and Education & Training Pharmacist, Croydon University Hospital The aim of this session is to discuss how professionalism, attitudes and values can be embedded into the workplace and addressing concerns. Learning outcomes: At the end of this session participants will be able to: Describe their view of professionalism Discuss various methods of dealing with a lack of professionalism and poor attitude through case studies Identify the challenges of embedding professionalism, attitudes and values into the workplace 11.00 11.30 12.00 12.30 b) Back to basics: Introduction to bacteriology and principles for use of common antibiotics (F) Adel Sheikh, UKCPA Pharmacy Infection Network Committee Member and Lead Pharmacist for Antimicrobials and Respiratory, Portsmouth Hospitals NHS Trust and David Sharpe, UKCPA Pharmacy Infection Network Committee Member and Antimicrobial Pharmacist, Alder Hey Children’s Foundation Trust The aim of this session is to provide an introduction to basic bacteriology & the principles for the use of commonly used antibiotics Learning outcomes: At the end of this session participants will be able to: Describe the four principal groups of pathogenic bacteria Identify the bacteria groups likely to be associated with different sites of infection Outline the spectrum of activity of the major antibiotic classes Recommend appropriate antibiotic combinations to cover common infections c) VTE- overcoming problems in management in specific patient groups (II) Rebecca Chanda, UKCPA Haemostasis, Anticoagulation and Thrombosis Group Committee Member and Highly Specialist Pharmacist Anticoagulation, Guy’s and St Thomas’ NHS Foundation Trust and Katherine Stirling, UKCPA Haemostasis, Anticoagulation and Thrombosis Group Committee Member and Consultant Pharmacist Anticoagulation, Leeds Teaching Hospitals NHS Trust The aim of this session is to discuss the common problems associated with VTE management in specific patient groups and discuss strategies for overcoming them. Learning outcomes: At the end of this session participants will be able to: Discuss the treatment of VTE in the following groups o IVDU o Pregnant o Patients with a VTE while on anticoagulation o Patients with anti-phospholipid syndrome o Patients with an IVC filter d) Recognising and managing sepsis in the non-ITU patient (F) Snehal Shah, Senior Pharmacist - Critical Care, Royal Brompton and Harefield NHS Foundation Trust and Fraser Hanks, Highly specialist pharmacist – Critical Care, Guy’s and St Thomas’ NHS Foundation Trust The aim of this session is to provide an insight into the recognition and management of sepsis in a patient in a non-critical care setting. Learning outcomes: At the end of this session participants will be able to: Explain the differences between SIRS, sepsis, septic shock Describe the incidence and mortality of sepsis Discuss the pathophysiology of sepsis Discuss the rationale behind the recommendations by the SSC 2013 o Fluid therapy o Antibiotics o Inotropes/vasopressors o Corticosteroids Apply these principles to real life patients e) Quality improvement; which tools and techniques to use in practice (F) Kevin Gibbs, UKCPA Medicines Safety and Quality Group Committee Member and Clinical Pharmacy Manager, University Hospitals Bristol The aim of this session is to discuss some tools and measurement techniques that support quality improvement within the workplace Learning outcomes: At the end of this session participants will be able to: Explain the principles behind elimination of waste in using Lean Select appropriate tools to use in local quality improvement initiatives Apply the Model for Improvement to any quality improvement measure Refreshments and poster exhibition Keynote Lecture: The future affordability of medicines, Speaker TBC UKCPA AGM/Association Update Poster Viewing Session, plus lunch and refreshments 12.40 13.40 13.50 14.10 14.30 14.45 15.00 Pain Management Satellite Meeting: CYP2D6: Its impact on pharmacological pain management, Drug-Drug Interactions and more, Dr Andrew Dickman, Consultant Pharmacist, Blackpool Teaching Hospitals NHS Foundation Trust, supported by Napp Pharmaceuticals Ltd Poster exhibition closes UKCPA 2014 Award Acknowledgements including the announcement of the hameln oral communication and best poster awards UKCPA Patient Safety Award 2014 – winner’s presentation Chair’s Closing Remarks Refreshments available to take into syndicate rooms Work session 3 (5 x concurrent sessions) a) Implications of the Francis Report on pharmacy education and training (I) Jill McDonald, joint Chair of the UKCPA Education & Training Group, Head of School of Pharmacy, Health Education Thames Valley and Pharmacist Manager – Education & Training, Milton Keynes Hospital NHS Foundation Trust The aim of this session is to discuss the main themes highlighted in the ‘Francis Report’ and how they impact on how we deliver education and training now and in the future. Learning outcomes: At the end of this session participants will be able to: List the main themes highlighted in the ‘Francis Report’ Discuss with your peers the recommendations from the ‘Francis Report’ which link to education and training and consider how they link to your practice Identify examples best practice and learning gaps within practice based learning and share ideas to support each other in the workplace b) Antimicrobial stewardship for the non-specialist (F) Laura Whitney, UKCPA Pharmacy Infection Network Committee Member and Consultant Pharmacist – Antimicrobials, St. Georges Hospital, London and Dr Diane Harris, UKCPA Community Group Committee Member and Lead Antimicrobial Pharmacist, Southern Derbyshire CCG The aim of this session is to provide an overview of antimicrobial stewardship (AS), its importance in tackling Healthcare Associated Infection (HAI) and how hospital and community/primary care pharmacists can contribute. Learning outcomes: At the end of this session participants will be able to: Explain why antimicrobial resistance and HAI are currently a priority within healthcare and why effective antimicrobial stewardship programme is required Discuss the role of an antimicrobial pharmacist and how all pharmacists can contribute to antimicrobial stewardship within their own area of practice c) Improving stroke prevention in AF: where are we now? (II) Frances Akor, Chair of the UKCPA Haemostasis, Anticoagulation and Thrombosis Group and Consultant Pharmacist, Anticoagulation, Imperial College Healthcare NHS Trust and Duncan McRobbie, UKCPA Haemostasis, Anticoagulation and Thrombosis Group Committee Member and Associate Chief Pharmacist - Clinical Services, Guy's & St Thomas' NHS Foundation Trust The aim of this session is to describe the update to the NICE recommendations for the management of AF, including treatment strategies for rate and rhythm control and acute management of AF anticoagulant management for prevention of stroke. Learning outcomes: At the end of this session participants will be able to: Provide an overview of the aetiology of atrial fibrillation Describe the recommendations by NICE on patients with AF including: o Assessment of patients with signs and symptoms of atrial fibrillation o Describe the treatment options for controlling heart rate and rhythm o Describe the anticoagulant management in patients with AF to prevent stroke o Describe the management of acute atrial fibrillation d) Intensive care sedation from the beginning (I/II) David Sapsford, UKCPA Critical Care Group and General Committee Member and Critical Care Pharmacist, West Suffolk Hospital NHS Foundation Trust The aim of this session is to critique and rationalise sedation strategies (both past and present) employed in Intensive Care. Learning outcomes: At the end of this session participants will be able to: Discuss the goals of sedation in Intensive Care and be able to describe both desirable and undesirable outcomes following sedation Explain the negative impact of delirium on a patient’s admission e) Managing the older surgical patient (II) Ruth Bosch, Advanced Pharmacist- Surgery and Orthopaedics, Glan Clwyd Hospital, Betsi Cadwaladr University Health Board and Derek Taylor, UKCPA Care of the Elderly Group Chair and Assistant 16.30 Director of Pharmacy- Governance and Risk, Royal Liverpool and Broadgreen University Hospitals NHS Trust The aim of this session is to discuss the additional medicines management considerations associated with the older surgical patient, with particular focus on fractured neck of femur patients. Learning outcomes: At the end of this session participants will be able to: Discuss the key principles for safe prescribing for older people during the peri-operative period. Describe the usual management pathway for a fractured neck of femur (#NOF) patient, and identify the key points where complications may occur Apply this knowledge to recommend appropriate symptom management and thromboprophylaxis regimens for older patients Outline the key evidence and national guidelines for pharmacological secondary prevention of fractures Symposium closes All our symposia work sessions have specific learning outcomes which will enable you to see how your practice will benefit from your attendance. We have also mapped these learning outcomes to the GLF and Advanced Pharmacy Framework (APF) so that you can easily identify the level that the work session is aimed at, and the professional development benefits you can achieve. Attending these work sessions will give you the opportunity to apply the knowledge learnt in order to achieve the competencies outlined in the APF. Don’t forget that you can enter your attendance at work sessions into your CPD or Faculty portfolio. Key to delivery level for work sessions, based on the GLF and APF: F = General Level, Foundation I = Advanced Stage I Hotel details: For details about the hotel, location and facilities, please visit: http://www.ichotelsgroup.com/h/d/cp/1/en/hotel/notws/transportation?start=1 Travel If you wish to plan your travel route direct, the following websites offer very accurate guidance: www.rac.co.uk, www.theaa.com, http://maps.google.co.uk/ There is a car park adjacent to the hotel with direct access by lift which has parking for 600 cars. Satellite and Fringe Meetings It is anticipated that there will be a number of meetings occurring throughout the symposium. Further information regarding these meetings will be emailed to delegates who have reserved a place prior to the symposium. Oral communication and poster presenters All authors will be advised if their submission has been accepted and presenters need to register as delegates. All oral communication and poster presenters MUST be members of UKCPA. Posters will be on display in their designated exhibition area from Friday at 15.40 until 13.40 on Saturday afternoon. The poster exhibition will officially open at 17.15 on Friday. Poster viewing will be available throughout this period but presenters are only required to stand by their posters to take questions on Saturday. N.B. Oral communication and poster winners will be announced during the Saturday afternoon plenary at 14.10. Social Event The symposium dinner will take place on the Friday evening. The evening will include the announcement of the UKCPA Lifetime Achievement Award 2014 winner. A disco will follow for those wishing to dance into the night. Symposium dinner dress code Most delegates wear black tie but lounge suits are perfectly acceptable. Non healthcare professionals are welcome at this dinner. Guests from the industry are asked to note this in accordance with the ABPI code of practice. Exhibition The Medical Exhibition will take place on Friday 21st November during which lunch and afternoon refreshments will be served. The UKCPA would like to encourage delegates to take advantage of the opportunity to visit the stands of exhibiting companies and organisations. II = Advanced Stage II M = Advanced Stage Mastery Registration Fees UKCPA members Non members 2 day symposium including accommodation and symposium dinner £350 £430 Twin/double room, fee per delegate £310 £400 Student rate, 2 days incl accommodation (limited spaces) £245 N/A 2 day non residential (excl accommodation/evening meals) £270 £370 Student rate, 2 day non residential (excl accomm/evening meals) £165 N/A Day delegate rate Friday £150 £200 Day delegate rate Saturday £150 £200 Symposium Dinner# £ 35 £ 35 (#if not attending as an accommodated symposium delegate) BPSA, PCPA and APTUK members are eligible to attend this symposium at the UKCPA members’ rates. To become a member of the UKCPA, please visit: http://www.ukcpa.net/join Industry representative registration fees: 2 day symposium incl accommodation Day delegate rate Friday Day delegate rate Saturday 2 day non residential (excl accomm/evening meals) £350* £150* £150* £640 £395 £395 £270* £530 *Industry representatives must be part of a UKCPA corporate members package to take advantage of the members rates. The UKCPA would encourage all delegates to attend both days to benefit from all aspects of the symposium and networking opportunities that take place. Day delegate rates do not include evening meals but do include refreshments and lunch. Contact Information: United Kingdom Clinical Pharmacy Association (UKCPA) 1st Floor, Publicity House, 59 Long Street, Wigston, Leicestershire, LE18 2AJ Tel: 0116 2889889, Fax: 0116 2889891 Email: [email protected], Website: www.ukcpa.org To register for this event, please visit: http://www.ukcpa.net/events/conferences/ukcpa-autumn-residential-symposium-2014 and complete the online registration form. To enable you to plan your time effectively at the symposium, an ‘at a glance grid’ version of this programme is available here: http://www.ukcpa.net/wpcontent/uploads/2014/06/Autumn-Symposium-at-a-glance-FINAL2.pdf. The UKCPA, on occasion, secures sponsorship from the pharmaceutical industry to support the financial costs for events that it organises. Industry partners providing this support are acknowledged on event flyers and programmes (correct at time of print). Symposium sponsorship goes towards supporting venue and audio visual costs, and various elements of delegate materials (badges, programmes, handouts, delegate lists, etc), UKCPA administration and nominal speaker honorariums and travel expenses. Sponsorship information can also be obtained by contacting Marie Matthews, UKCPA General Manager, tel: 0116 2889889 or email: [email protected] The UKCPA is committed to working with all its industry partners within the ABPI's Code of Practice.
© Copyright 2018